← Back to Search

Tibial Nerve Stimulation

eCoin for Urge Urinary Incontinence (RECIPE Trial)

N/A
Recruiting
Research Sponsored by Valencia Technologies Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individual is mentally competent and able to understand all study requirements
Individual has at least one urgency urinary incontinence episode on each of three days as determined on a 3-day voiding diary
Must not have
Individual has an active urinary tract infection at time of enrollment
Individual has significant lower urinary tract pain or has been diagnosed with interstitial cystitis or bladder pain syndrome
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12, 24, 36, 48, and 60 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a small device called eCoin® that is placed under the skin near the ankle. It sends electrical signals to a nerve that helps control the bladder. The study focuses on people who have trouble controlling their bladder and experience sudden urges to urinate. The goal is to see if this device can safely and effectively reduce these symptoms over time. The eCoin is a nickel-sized, battery-powered device implanted in the lower leg to treat overactive bladder, and has been evaluated in previous studies for its safety and effectiveness.

Who is the study for?
This trial is for adults over 18 with urgency urinary incontinence who haven't had success with certain other treatments. Candidates should be able to track their bathroom visits and not be pregnant, have bladder cancer history, or severe conditions like uncontrolled diabetes that could affect the study.
What is being tested?
The eCoin Tibial Nerve Stimulation device is being tested for safety and effectiveness in treating overactive bladder symptoms. Participants will receive the implant and record their symptoms for a year to see if there's at least a 50% improvement.
What are the potential side effects?
Possible side effects may include discomfort at the implant site, skin irritation or infection, bleeding complications especially if on blood thinners, nerve-related issues in lower extremities, and potential interference with certain medical devices.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I understand all the study requirements and can make decisions.
Select...
I've had sudden urges to urinate that I couldn't control, at least once a day for three days.
Select...
I have been diagnosed with an overactive bladder that causes sudden urges to urinate.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I currently have a urinary tract infection.
Select...
I have severe bladder pain or have been diagnosed with interstitial cystitis.
Select...
My diabetes is not under control, with an A1C level over 7.
Select...
I have a urinary fistula, bladder stone, or interstitial cystitis.
Select...
I have artery disease in my legs.
Select...
I frequently urinate more than usual.
Select...
I have long-term vein problems with skin changes near my ankle.
Select...
I have skin issues or infections in my lower legs.
Select...
I had surgery for stress incontinence less than a year ago.
Select...
I have a skin condition like dermatitis at the planned surgery site.
Select...
I have bladder control issues due to nerve problems.
Select...
I have vasculitis in my legs.
Select...
I am using a TENS unit for pain in my pelvic area, back, or legs.
Select...
I have had surgery or significant scarring where the implant will be placed.
Select...
I have open wounds or had surgery on my legs.
Select...
I have been diagnosed with cancer of the bladder, urethra, or prostate.
Select...
I have painful varicose veins.
Select...
I do not have severe swelling at the site of my implant.
Select...
I have severe nerve pain or numbness in my legs.
Select...
I have a weakened immune system.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12, 24, 36, 48, and 60 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12, 24, 36, 48, and 60 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Responder Rate
Safety
Secondary study objectives
Safety Data
Safety data through 7 months post-reimplantation.
Other study objectives
Device-related adverse events from implantation.
Patient reported overactive bladder condition improvement.
Patient reported qualify of life
+11 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: eCoin Tibial Nerve StimulationExperimental Treatment1 Intervention
Subcutaneous stimulation of the tibial nerve using the eCoin device.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
eCoin Tibial Nerve Stimulation
2018
N/A
~160

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The most common treatments for Urge Incontinence include pharmacological therapies, behavioral interventions, and neuromodulation techniques such as tibial nerve stimulation. Tibial nerve stimulation, like the eCoin® implanted tibial nerve stimulator, works by sending electrical impulses to the tibial nerve, which in turn modulates the neural pathways that control bladder function. This can help reduce the frequency and urgency of urination by improving the communication between the bladder and the brain. For patients with Urge Incontinence, this matters because it offers a minimally invasive option that can effectively manage symptoms and improve quality of life without the side effects associated with medications.

Find a Location

Who is running the clinical trial?

Valencia Technologies CorporationLead Sponsor
5 Previous Clinical Trials
249 Total Patients Enrolled

Media Library

eCoin (Tibial Nerve Stimulation) Clinical Trial Eligibility Overview. Trial Name: NCT05685433 — N/A
Urge Incontinence Research Study Groups: eCoin Tibial Nerve Stimulation
Urge Incontinence Clinical Trial 2023: eCoin Highlights & Side Effects. Trial Name: NCT05685433 — N/A
eCoin (Tibial Nerve Stimulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05685433 — N/A
~47 spots leftby Aug 2025